An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma. - Reichardt,P.; Oechsle,K.; Pink,D.; Bokemeyer,C.; Schneller,F.; Issels,R.; Kanz,L.; Hartmann,JT. (Invest New Drugs, 2003)